Menu
Back to Journals » Cancer Management and Research » Volume 15
Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells [Retraction]
Hao JF, Chen P, Li HY, Li YJ, Zhang YL. Cancer Manag Res. 2020;12:13347–13356
The Editor and Publisher of Cancer Management and Research are retracting the published article. An investigation found images from Figure 5 had been duplicated. Specifically,
- The image for Figure 5C, 769-P, miR-214-3p-mimics+pcDNA3.1-HCP5 has been duplicated with the same image for Figure 5C, 769-P, miR-214-3p-inhibit+si-HCP5#1.
The authors cooperated with the investigation and provided data associated with the reported study. However, despite the authors’ assistance, a satisfactory explanation for how the images came to be duplicated could not be provided, and the validity of the published work could not be verified. The decision was made to retract the article and the authors agree with this.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.